Bedankt voor je registratie!

Voorstel studie embolen IBC - Peter Vermeulen

Celvrij circulerend DNA - Luc Dirix

Update stolling en levermetastasen @ TCRU - Emily Latacz

Update onderzoek levermetastasen @ TCRU - Peter Vermeulen

Post ESMO: evoluties behandeling borstkanker - Philip Poortmans

Post ESMO: evoluties behandeling borstkanker - Kevin Punie

AI modellen ontwikkeld door de onderzoeksgroep RADar - Peter De Jaegher (Chief Innovation Officer, RADar, AZ Delta, Roeselare)

Cell competition promotes metastatic intestinal cancer through a multistage process - Peter Vermeulen

Clinical significance of ctDNA in early-stage breast cancer - Luc Dirix

Preoperative Radiation Therapy for Breast Cancer - Melanie Machiels

Kankerstamcellen en dikke darmcarcinomen - Peter Vermeulen

Post-ASCO borstkanker - Kevin Punie

Kankerstamcellen en dikke darmcarcinomen - Peter Vermeulen

Are we entering a period of managed decline in (radiation) oncology? - Piet Dirix

Patient reported outcomes in cancer care - a paradigm change is evident - Michel Guerchaft - Elekta NV/SA

CDKi 4/6 resistentie - Luc Dirix

Histopathologische heterogeniteit van metastatische borstkanker - Maxim De Schepper (KU Leuven)

Not all that shines turns out to be gold - Guy Storme

Development and validation of a neural image compression pipeline to predict survival after surgery for colorectal liver metastases - Peter Vermeulen

Voorstelling Zeiss Tumor Workflow IORT Intrabeam 600 - Magaly Verlinden (Zeiss)

Histopathologische heterogeniteit van metastatische borstkanker - Maxim De Schepper (KU Leuven)

Somatic Mutations and Cellular Plasticity - Luc Dirix

Presentation of the pre-clinical CBCT and x-ray irradiation system Smart+IB (Precision X-Ray - Tromp Medical) - Pieter De Clerck (Tromp Medical)

Update on the pre-clinical FLASH research - Pierre Montay-Gruel

Progressie PhD-thesis Kliniek Familiale Kanker – Margo Mahieu

Verslag van de derde OLiver-meeting (nationaal initiatief wetenschappelijk onderzoek levermetastasen) - Peter Vermeulen

Circulerend tumor-DNA en adjuvante chemotherapie bij het operabel coloncarcinoom - Luc Dirix

Biomarkers voor anti-EGFR resistentie bij het colorectale adenocarcinoom - Ana Regina de Abreu

Opleiding Project management deel 2 - Ilse Van Der Auwera

Biobanking van prostaatkankerweefsel - Peter Vermeulen

Lineage plasticity and chemoresistance - Luc Dirix

A cellular hierarchy in melanoma uncouples growth and metastasis. - Peter Vermeulen

The histopathological growth patterns of breast cancer liver metastases: prognostic study and TIL assessment. - Sophia Leduc (KU Leuven)

Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models. - Emily Latacz

PI3K en goedaardige tumoren - Luc Dirix

Axillary radiotherapy, AMAROS and Z0011 paradigms. - Melanie Machiels

Polymerase epsilon en immuun-checkpointinhibitoren bij het endometriumcarcinoom. - Luc Dirix

Opleiding over het projectmanagement voor een ‘investigator-initiated’ studie- Ilse Van Der Auwera

Immunohistochemical Characterization of the Immune Landscape in Primary Uveal Melanoma and Liver Metastases - Peter Vermeulen

Towards a patient-tailored breast cancer treatment and de-escalation of treatment burden - Redouane Oulkadi

Predictors of response to neoadujvant aromatase inhibition in menopausal patients with ER+ breast cancer. - Luc Dirix

Progressie van de POEM-studie - Emily Latacz

The histopathological growth patterns of colorectal peritoneal metastases and evaluation of their prognostic impact - Peter Vermeulen

Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution - Peter Vermeulen

Course Systematic review Cochrane Belgium: tips & tricks - Emily Latacz

Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage - Peter Vermeulen

Lymph node colonization induces tumor-immune tolerance to promote distant metastasis - Piet Dirix

'FLASH Updates' - Alessia Gasparini

Cel position matters for tumour-driving mutations - Luc Dirix

Tissue factor en andere CAF-merkers in colorectale levermetastasen - Peter Vermeulen

Adjuvant versus early salvage radiation therapy after radical prostatectomy for pN1 prostate cancer and the risk of death (Derya Tilki et al.) - Piet Dirix

Feedback jaarlijkse meeting AACR - Luc Dirix/Peter Vermeulen

Immune checkpoint inhibitors in renal transplant patients - Tess Meerhaeghe

Tussentijdse rapportering masterthesis 'Stolling en de groeipatronen van levermetastasen' - Laura Vanderschelde

Breast cancer liver metastases: the histopathological growth patterns and the TILs - Sophia Leduc

11 ESMO 2021 breakthroughs: practicing oncologist's perceptions on data presentation - Michiel Strijbos

To boost or not to boost - Melanie Machiels

LTBP2+ CAFs Modulate Desmoplastic Reaction in Colorectal Cancer-Liver Metastases - Emily Latacz

'Oefenen PhD-thesisvoordracht - Groeipatronen van levermetastasen' - Pieter-Jan van Dam

Stereotactische microgolfablatie van levertumoren - Thierry Chapelle

3D- geprint muisfantoom - Alessia Gasparini

XIAP expression is associated with an immunosuppressive and exhausted immune micro-environment in inflammatory breast cancer - Christophe Van Berckelaer

Single cell analysis of TME in dormant minimal residual disease - Luc Dirix

Can genomic risk be used to tailor radiation therapy? - Philip Poortmans

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial - Piet Dirix

Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes - Peter Vermeulen

De Hippo-signaalweg in levertumoren - Peter Vermeulen

Wetenschappelijk 5-jarenplan Iridium 'SBRT' - Charlotte Billiet

Obesitas en het inflammatoire borstcarcinoom - Maxim De Schepper (KULeuven)

ESTRO-ACROP prostate bed contouring - Piet Dirix

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA

Oncologisch Centrum GZA